N A Mankodi - JoVE Visualize

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

British Journal of Clinical Pharmacology|November 1, 1983

Phase 1 tolerability and antiamoebic activity studies with 1-methylsulphonyl-3-(1-methyl-5-nitro-2-imidazolyl)-2-imidazolidinone (Go.10213): a new antiprotozoal agentA B Vaidya, D K Ray, N A Mankodi, et al.

British Journal of Clinical Pharmacology|August 1, 1977

Phase 1 tolerability and searching dose studies with 4-isothiocyanato-4'-nitrodiphenylamine (C.9333-Go/CGP 4540), a new anthelminticA B Vaidya, H G Sen, N A Mankodi, et al.

The American Journal of Tropical Medicine and Hygiene|July 1, 1977

Clinical trials of a new anthelmintic, 4-isothiocyanato-4'-nitrodiphenylamine (C.9333-Go/CGP 4540), for the cure of hookworm infectionJ C Doshi, A B Vaidya, H G Sen, et al.

Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

British Journal of Clinical Pharmacology|November 1, 1983

Phase 1 tolerability and antiamoebic activity studies with 1-methylsulphonyl-3-(1-methyl-5-nitro-2-imidazolyl)-2-imidazolidinone (Go.10213): a new antiprotozoal agentA B Vaidya, D K Ray, N A Mankodi, et al.

British Journal of Clinical Pharmacology|August 1, 1977

Phase 1 tolerability and searching dose studies with 4-isothiocyanato-4'-nitrodiphenylamine (C.9333-Go/CGP 4540), a new anthelminticA B Vaidya, H G Sen, N A Mankodi, et al.

The American Journal of Tropical Medicine and Hygiene|July 1, 1977

Clinical trials of a new anthelmintic, 4-isothiocyanato-4'-nitrodiphenylamine (C.9333-Go/CGP 4540), for the cure of hookworm infectionJ C Doshi, A B Vaidya, H G Sen, et al.

Pageof 1